Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

DEXTERA SURGICAL INC (DXTR)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-17Jun-30-17Mar-31-17Dec-31-16Sep-30-16Jun-30-16Mar-31-16Dec-31-15
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Net revenue:          
Product sales, net  3.23.12.82.22.22.52.62.7
License and development revenue  0.40.30.31.61.51.51.4 
Royalty revenue  0.10.10.10.10.10.10.10.1
    Total net revenue  3.73.43.13.93.84.14.02.7
            Total net revenue growth  -3.1%-15.6%-23.6%42.1%40.7%35.6%22.0%-26.2%
Operating costs and expenses:          
Cost of product sales  4.23.83.83.43.43.93.73.6
Research and development  6.56.66.76.26.56.36.67.0
Selling, general and administrative  7.57.78.48.58.89.48.99.2
    Total operating costs and expenses  18.218.018.918.218.619.619.219.7
    Loss from operations  -14.6-14.6-15.8-14.4-14.9-15.6-15.2-17.0
            Operating margin  -399.6%-426.3%-511.6%-371.8%-394.2%-383.6%-376.0%-625.2%
Interest income  0.00.00.00.10.10.10.10.1
Interest expense  -0.6-0.5-0.5-0.5-0.5-0.5-0.5-0.5
Other income (expense), net  -1.7-2.10.00.00.00.00.00.0
    Net loss  -16.8-17.2-16.3-14.9-15.3-16.0-15.6-17.4
Deemed dividend attributable to convertible preferred stock  -8.8-8.7      
    Net loss allocable to common stockholders  -29.6-29.9  -19.9-16.0  
   
Basic net loss per share allocable to common stockholders (in dollars per share)  ($1.98)($2.33)($1.82)($1.66)($1.71)($1.79)($1.76)($1.96)
Diluted net loss per share allocable to common stockholders  ($1.98)($2.33)($1.82)($1.66)($1.71)($1.79)($1.76)($1.96)
   
Shares used in computing basic net loss per share allocable to common stockholders  17.99.58.98.98.98.98.98.9
Shares used in computing diluted net loss per share allocable to common stockholders  18.59.58.98.98.98.98.98.9

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy